clofarabine has been researched along with Experimental Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gilbert, KS; Parker, WB; Shaddix, SC; Shepherd, RV; Waud, WR | 1 |
| Gilbert, KS; Scoggins, JW; Stackhouse, MA; Waud, WR | 1 |
2 other study(ies) available for clofarabine and Experimental Neoplasms
| Article | Year |
|---|---|
Enhancement of the in vivo antitumor activity of clofarabine by 1-beta-D-[4-thio-arabinofuranosyl]-cytosine.
Topics: Adenine Nucleotides; Animals; Antineoplastic Agents; Arabinonucleosides; Clofarabine; Drug Synergism; Drug Therapy, Combination; Humans; Mice; Mice, Nude; Mice, SCID; Neoplasms, Experimental; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2009 |
Preclinical combination therapy of clofarabine plus radiation.
Topics: Adenine Nucleotides; Animals; Antineoplastic Agents; Arabinonucleosides; Cell Line, Tumor; Clofarabine; Combined Modality Therapy; Deoxycytidine; Drug Evaluation, Preclinical; Gemcitabine; Humans; Mice; Mice, Nude; Neoplasms, Experimental; Tumor Burden; Xenograft Model Antitumor Assays | 2012 |